Skip to main content
. 2017 Aug 22;7:9153. doi: 10.1038/s41598-017-09655-7

Figure 6.

Figure 6

BHX reduces the growth of MDA-MB-231 tumours in vivo. (a) Bioluminescent imaging of MDA-MB-231 tumours at 0 and 21 days after treatment with BHX or vehicle. (b) Quantification of bioluminescent intensity in response to administration of BHX or vehicle after 0 and 21 days of treatment. (c) Tumour volume and (d) body weight were measured every 5 days after treatment with BHX or vehicle. Data are represented as means ± S.D. (n = 5). # p < 0.05 and ## p < 0.01.